Literature DB >> 30513018

Assay challenges (and opportunities) with non-factor VIII therapies for Hemophilia A.

Maria M Aleman1, Nina C Leksa1, Robert Peters1, Joe Salas1.   

Abstract

Entities:  

Keywords:  Hemophilia A; aPTT; bypassing agent; chromogenic assay; thrombin generation

Mesh：

Substances：

Year:  2018        PMID： 30513018     DOI： 10.1080/14737159.2019.1554436

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN： 1473-7159            Impact factor:   5.225


× No keyword cloud information.
  3 in total

1.  Expert opinion on current and future prophylaxis therapies aimed at improving protection for people with hemophilia A.

Authors:  Angelika Batorova; Ana Boban; Melen Brinza; Toshiko Lissitchkov; Laszlo Nemes; Irena Zupan Preložnik; Petr Smejkal; Nadezhda Zozulya; Jerzy Windyga
Journal:  J Med Life       Date:  2022-04

Review 2.  Laboratory monitoring of hemophilia A treatments: new challenges.

Authors:  Peter J Lenting
Journal:  Blood Adv       Date:  2020-05-12

Review 3.  Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine.

Authors:  François Depasse; Nikolaus B Binder; Julia Mueller; Thomas Wissel; Stephan Schwers; Matthias Germer; Björn Hermes; Peter L Turecek
Journal:  J Thromb Haemost       Date:  2021-09-26       Impact factor: 16.036
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.